Therefore, Ang-1 should be examined in combination with additional angiogenic factors, including Ang-2 and VEGF, in order to draw a more accurate conclusion considering lung cancer progress and recurrence [23,45]. This evidence concerns the gene VEGFA and lung carcinoma.